Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases
Top Cited Papers
- 1 January 2018
- journal article
- review article
- Published by Elsevier BV in Journal of Ethnopharmacology
- Vol. 210, 296-310
- https://doi.org/10.1016/j.jep.2017.08.035
Abstract
No abstract availableKeywords
This publication has 117 references indexed in Scilit:
- Clustering of Risk Factors: A Simple Method of Detecting Cardiovascular Disease in YouthPEDIATRICS, 2011
- Unanticipated Benefits of CAM Therapies for Back Pain: An Exploration of Patient ExperiencesThe Journal of Alternative and Complementary Medicine, 2010
- Hepatotoxicity of high oral dose (−)-epigallocatechin-3-gallate in miceFood and Chemical Toxicology, 2010
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2010
- Beneficial effects of green tea: A literature reviewChinese Medicine, 2010
- Inflammatory biomarkers in coronary artery diseaseJournal of Cardiology, 2009
- Green Tea (–)-Epigallocatechin-3-Gallate Reduces Body Weight with Regulation of Multiple Genes Expression in Adipose Tissue of Diet-Induced Obese MiceAnnals of Nutrition and Metabolism, 2009
- Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trialBritish Journal of Nutrition, 2008
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectivesPhytochemistry, 2006